DEVELOPMENT OF M102 TO INVESTIGATIONAL NEW DRUG (IND) STAGE FOR INITIATION OF PHASE I CLINICAL TRIALS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS (ALS)

Aclipse One Inc

Investigators